financetom
Business
financetom
/
Business
/
French antitrust clears Carrefour's acquisition of Delhaize's French business
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
French antitrust clears Carrefour's acquisition of Delhaize's French business
Mar 13, 2025 4:49 AM

PARIS (Reuters) - French antitrust authority said on Thursday it had approved the acquisition by Carrefour of the French business of Belgian retailer Louis Delhaize on the condition that eight stores would be sold to competitors.

Carrefour said in a separate statement it would start talks with potential buyers with the goal to sell the eight stores -- five hypermarkets and three supermarkets with total sales slightly above 300 million euros, by end 2025.

The deal clinched with Louis Delhaize gives Carrefour control over the Cora and Match stores in France as well as the Provera purchasing unit, Carrefour added, confirming a goal to generate synergies of 130 million euros by 2027 from the acquisition.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Johnson & Johnson Says Tremfya Reduces Psoriatic Arthritis Signs, Symptoms in Phase 3b Trial
Johnson & Johnson Says Tremfya Reduces Psoriatic Arthritis Signs, Symptoms in Phase 3b Trial
Jun 11, 2025
09:17 AM EDT, 06/11/2025 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Wednesday that results from its phase 3b Apex trial demonstrated that monoclonal antibody Tremfya significantly reduced signs and symptoms of active psoriatic arthritis and inhibited progression of joint structural damage at 24 weeks compared with placebo. The company said 67% and 63% of patients who received...
Ouster Stock Is Surging Wednesday: Here's Why
Ouster Stock Is Surging Wednesday: Here's Why
Jun 11, 2025
Ouster Inc ( OUST ) shares are trading higher Wednesday after the company announced that its OS1 digital lidar was approved by the Department of Defense for use in unmanned aerial systems. What To Know: Ouster said the Defense Innovation Unit completed a review of components and cybersecurity testing and approved and added the Ouster OS1 to the Blue unmanned aerial...
Talen Energy and Amazon sign nuclear power deal to fuel data centers
Talen Energy and Amazon sign nuclear power deal to fuel data centers
Jun 11, 2025
(Reuters) -U.S. utility Talen Energy ( TLN ) announced on Wednesday an expanded nuclear energy partnership with Amazon.com ( AMZN ) to supply up to 1,920 megawatts of electricity from its Susquehanna plant in Pennsylvania to Amazon Web Services (AWS) data centers. WHY IT'S IMPORTANT The long-term deal, lasting until 2042, ensures Talen a steady, long-term revenue stream while supporting...
Copyright 2023-2026 - www.financetom.com All Rights Reserved